ArticleFrontiers in pharmacology2026

5-methoxyresorcinol mitigates postmenopausal osteoporosis through regulation of the PI3K-AKT-GSK3β signaling pathway and ROS homeostasis.

Maosheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.